Searched for
AUROBINDO PHARMA Q1 PROFIT
Ashok Leyland just had a record June quarter. So why did the margin fall a full point?Ashok Leyland's June-quarter has an unusual contradiction. The company sold 48,763 commercial vehicles, its highest-ever first-quarter volu...- Cupid shares hit fresh 52-week high as firm raises FY27 revenue, profit guidance again; multibagger stock skyrockets 617% in a yearCupid shares hit a 52-week high after raising its FY27 guidance for the second time in two weeks, targeting Rs 800 crore revenue and Rs 250...
- Stocks in news: Infosys, HDFC Bank, Jio Financial, IRFC, NCC and Blue DartIndian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...
- Market wrap: Kotak Mahindra Bank, InterGlobe, Apollo Hospital, Max Healthcare top gainers and losers on Nifty and Sensex on WednesdayIndian equities extended their decline on Wednesday, with Nifty slipping below 22,650 as selling pressure persisted at higher levels. Healt...
- Q2 earnings: Can India Inc repeat Q1, or will Q3 erase the base-effect tailwind?India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...
- Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s whyLenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA mar...
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty’s indicative price plunged 2% in two seconds during the closing auction session on monthly expiry, before recovering sharply. Analyst...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Honasa Consumer shares fall 5% after Rs 643 crore block deal; Peak XV, Sequoia likely sellersHonasa Consumer shares declined up to 5% after 1.4 crore shares worth Rs 643 crore changed hands in a block deal. The transaction comes aft...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
- Goldman Sachs sees Eternal achieving $1 billion EBITDA by FY29; raises target priceGoldman Sachs maintained a Buy rating on Eternal, formerly Zomato, raising its target price by 11% to Rs 385. The brokerage foresees Eterna...
- MongoDB stocks crash at Nasdaq: In 2025, MDB share price jumped over 30 per cent, one year later company stocks suffer Wall Street's biggest losses after Meta's latest recruitment moveMongoDB share price today: MongoDB is a software company that provides a cloud-based database platform used to build and run modern applica...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Suzlon Energy shares fall 2% to near six-month low, down 15% in one monthSuzlon Energy shares slipped over 2% to a near six-month low, approaching their 52-week low amid higher trading volumes and broader market ...
- Petronet to pay directors up to 1% of profit as commissionPetronet LNG Ltd has proposed to seek shareholders' approval for paying commissions to directors from FY27 to FY31. This proposal is for a ...
- Accel India, 360 ONE Group sell over 4% stake in BlueStone for Rs 513 croreThe two investors sold a combined 61.98 lakh shares on Thursday, representing a 4.07% stake in Bengaluru-based BlueStone Jewellery and Life...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities suffered a sharp selloff, with Sensex plunging 1,248 points and Nifty falling 1.6% as US Treasury yields hit 19-year highs,...
- Decoding GDP growth: The good, the bad & the dataET drew up a longlist of more than five dozen indicators across all key themes of the economy— from the external sector and markets to farm...
- 10 midcap stocks post highest quarterly profit in 10 quartersTen NSE midcap stocks recorded their highest quarterly net profits in the June 2026 quarter, with each surpassing its previous peak over th...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
Load More
